Your browser doesn't support javascript.
loading
Navigating through the healthcare system with atopic dermatitis: Analysing patient journeys in Germany.
Tizek, Lu; Tizek, Li; Schneider, S; Wecker, H; Welzel, J; Biedermann, T; Zink, A.
Afiliação
  • Tizek L; School of Medicine, Department of Dermatology and Allergy, Technical University of Munich, Munich, Germany.
  • Tizek L; School of Medicine, Department of Dermatology and Allergy, Technical University of Munich, Munich, Germany.
  • Schneider S; School of Medicine, Department of Dermatology and Allergy, Technical University of Munich, Munich, Germany.
  • Wecker H; School of Medicine, Department of Dermatology and Allergy, Technical University of Munich, Munich, Germany.
  • Welzel J; Clinic for Dermatology and Allergology, University Hospital Augsburg, Augsburg, Germany.
  • Biedermann T; School of Medicine, Department of Dermatology and Allergy, Technical University of Munich, Munich, Germany.
  • Zink A; School of Medicine, Department of Dermatology and Allergy, Technical University of Munich, Munich, Germany.
Article em En | MEDLINE | ID: mdl-39087748
ABSTRACT

BACKGROUND:

Atopic dermatitis (AD), which can significantly impact quality of life, is a complex, heterogeneous skin disease affecting all ages and therefore can lead to very different patient journeys. Understanding the patient journey within the healthcare system is essential for improving care outcomes.

OBJECTIVES:

To explore the patient journey of individuals with AD in Germany, with a specific focus on the utilization of Internet resources throughout this process.

METHODS:

A cross-sectional study using a self-administered questionnaire was conducted from June 2021 to February 2022. Participants were recruited from dermatology private practices, a university hospital and online platforms.

RESULTS:

The study included 276 participants (62.3% female; mean age 46.3 ± 18.4 years; mean disease duration 26.9 ± 17.5 years; mean DLQ Index 10.0 ± 5.6). Around 191 participants were currently receiving medical treatment, with 9.1% receiving biologic therapy. Most of the people initially contacted a GP (42.4%) and were diagnosed by a dermatologist first (57.6%). Around 47.1% were currently in treatment by a dermatologist, seeking dermatological care on average 4.5 times a year. Almost all individuals (86.2%) have already consulted more than one physician during their patient journey. Overall, participants consulted a median of five physicians, while those with severe AD consulted a median of six physicians. Initial symptoms to diagnosis and between consulting two different physicians both had a median duration of 6 months. Dissatisfaction with treatment outcomes emerged as a common reason for changing physicians. Approximately 76.4% of participants used the Internet for disease-related information, primarily relying on Google. Overall, 63% found the information quality unsatisfactory.

CONCLUSION:

The study underlines the widespread utilization of medical treatment and the proactive healthcare-seeking behaviour during a long patient journey. Dissatisfaction with treatment outcomes, alternative medicine and the quality of the Internet sources emphasize the potential for improving the comprehensive disease management to improve care outcomes.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Eur Acad Dermatol Venereol / J. Eur. Acad. Dermatol. Venereol / Journal of the European Academy of Dermatology and Venereology Assunto da revista: DERMATOLOGIA / DOENCAS SEXUALMENTE TRANSMISSIVEIS Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Eur Acad Dermatol Venereol / J. Eur. Acad. Dermatol. Venereol / Journal of the European Academy of Dermatology and Venereology Assunto da revista: DERMATOLOGIA / DOENCAS SEXUALMENTE TRANSMISSIVEIS Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Alemanha